
Actuated Medical, based in Bellefonte, US, specializes in R&D, design, and manufacturing of medical devices.
Actuated Medical, founded in Bellefonte, US, focuses on improving patient outcomes through innovative motion technologies. The company's core mission is to design, model, prototype, and manufacture advanced medical devices that enhance clinical procedures. Their primary products include devices for occlusion clearing and intelligent tissue penetration, leveraging expertise in acoustic design, fluid dynamics, electronics, and software development. Actuated Medical targets the healthcare market, aiming to provide solutions that maintain critical patency and improve tissue insertion processes.
Notable affiliated individuals include the company's founder and key investors who have supported its growth in the medical device sector. Actuated Medical has achieved significant milestones, including the development of proprietary technologies that have been adopted in various clinical settings. Their impact is evident in the improved efficiency and effectiveness of medical procedures, contributing to better patient care and outcomes. The company's innovative approach and specialized expertise have positioned it as a leader in the medical device industry.

Xact Medical
xactmedical.com

Ativa Medical

Advanced Medical Device Technologies
advancedmdt.com

Advanced Catheter Therapies
acatheter.com

IntuiTap Medical

Intact Medical

Agile Devices
agiledevices.com

Medical Device Innovations

RxActuator

East End Medical

Control Medical Technology

Adient Medical
adientmedical.com

Infused Medical Technology

Proa Medical
proamedical.com

Cirtec Medical
cirtecmed.com
Companies similar to Actuated Medical include Xact Medical, Ativa Medical, Advanced Medical Device Technologies and Advanced Catheter Therapies.
Actuated Medical was founded in 2006.
Actuated Medical's headquarters is located in Bellefonte, PA, US.
As of Dec 6, 2022, Actuated Medical has raised a total of $1.6M (USD).
Actuated Medical has 33 employees as of Feb 5, 2024.